Evidence map›Paper›PMID 32686047›Full record

Trial reportTranslational stroke research2021

Carotid Endarterectomy and Stenting in a Chinese Population: Safety Outcome of the Revascularization of Extracranial Carotid Artery Stenosis Trial.

Bin Yang, Yan Ma, Tao Wang, Yanfei Chen, Yinzhou Wang, Zhenwei Zhao, Dong Chen, Jiyue Wang, Xiaolin Xu, Tao Luo and 6 more

2 registry-linked trialsAbstract readClinical TrialMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Translational stroke research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01994187 unknown statusnot on this map

the Clinic Registration Study of Carotid Stenosis Revascularization

Typeobservational_patient_registrySponsorXuanwu Hospital, BeijingRan2013 to 2015Enrolled2,100ConditionsCarotid Stenosis, Surgery, StrokeArmsCarotid endarterectomy, carotid angioplasty
NCT07370246 narecruitingnot on this mapstarted 2026, after this paper: background citation

Evaluating the Safety and Efficacy of the Carotid Artery Stenting System for Stenosis With High-risk Features for CEA: a Prospective, Multicenter, Single-group Target-value Study in China

TypeinterventionalSponsorBeijing Tiantan HospitalRan2026 to 2028Enrolled212ConditionsCarotid Artery Stenosis, Carotid Artery StentingArmsCarotid artery stent system
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bin Yang *Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.
Yan Ma *Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.
Tao Wang *Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.
Yanfei ChenDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.
Yinzhou WangDepartment of Neurology, Fujian Provincial Hospital, Fuzhou, Fujian, China.
Zhenwei ZhaoDepartment of Neurosurgery, Tangdu Hospital, Xian, Shanxi, China.
Dong ChenDepartment of Neurosurgery, Dalian Municipal Central Hospital, Dalian, Liaoning, China.
Jiyue WangDepartment of Neurosurgery, Liaocheng Brain Hospital, Liaocheng, Shandong, China.
Xiaolin XuDepartment of Neurology, Huanhu Hospital, Tianjin, China.
Tao LuoDepartment of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
Yang HuaDepartment of Vascular Ultrasonography, Xuanwu Hospital, Capital Medical University, Beijing, China.
Feng LingDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.
Adnan I QureshiZeenet Qureshi Stroke Institute, St Cloud, MN and Department of Neurology, University of Missouri, Columbia, MO, USA.
Bo HongDepartment of Neurosurgery, Changhai Hospital, No. 168, Changhai Road, Shanghai, China. hongbosmmu@vip.126.com.
Liqun JiaoDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China. liqunjiao@sina.cn.ORCID http://orcid.org/0000-0003-4982-6295
RECAS Trial Investigators

Funding

the Beijing Scientific and Technologic Project D161100003816002the National Key Research and Development Project 2016YFC1301703the National Science and Technology Support Program 2011BAI08B04
6 · The paper itself

Abstract

Carotid endarterectomy (CEA) and carotid artery stenting (CAS) have been well-established as two effective treatment modalities for carotid artery stenosis, while their clinical outcomes in real-world China are still unknown due to lack of nationwide trials. We aimed to evaluate the safety outcome profile of CEA and CAS in Chinese patients with carotid artery stenosis. The Revascularization of Extracranial Carotid Artery Stenosis trial was a multicentre, prospective cohort study of CEA or CAS in treating patients with carotid artery stenosis. We included symptomatic or asymptomatic patients with carotid artery stenosis (≥ 50%). The primary endpoint was any stroke, myocardial infarction and/or death within 1 month post-procedure. Overall, 2719 cases (1543 CAS-treated patients and 1176 CEA-treated patients) were enrolled from 36 centres. The primary outcome was 4.3% (95% CI 3.2-5.6%) and 4.7% (95%CI 3.5-6.3%) in the symptomatic and asymptomatic patients, respectively. No significant difference in the primary outcome was found between CAS and CEA in both symptomatic (p = 0.338) and asymptomatic (p = 0.890) patients. High- versus low-volume centre significantly related to lower rate of primary outcome in CEA-treated patients (OR 2.54; 95%CI 1.19-5.44; p = 0.017) and asymptomatic patients (OR 2.54; 95%CI 1.42-4.54; p = 0.002). CEA and CAS decided by surgeons' discretion have comparable risks among patients with carotid artery stenosis in China. Both CEA and CAS should be avoided in asymptomatic patients until a consistently low complication rate is showed with centre-level audits. Medical treatment for patients with carotid stenosis in China needs to be improved. Trial registration: NCT01994187 ( ClinicalTrials.gov ).

Indexed as

Carotid StenosisEndarterectomy, CarotidStrokeHumansProspective StudiesStentsTreatment OutcomeCarotid artery stenosisCarotid artery stentingCarotid endarterectomyStroke

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.